Legato Capital Management’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.12M Buy
45,855
+8,350
+22% +$337K 0.18% 175
2026
Q1
$1.24M Sell
37,505
-2,930
-7% -$95.3K 0.11% 238
2025
Q4
$1.32M Buy
+40,435
New +$994K 0.11% 289
2025
Q2
Sell
-50,986
Closed -$943K 568
2025
Q1
$943K Buy
50,986
+16,462
+48% +$297K 0.13% 269
2024
Q4
$569K Buy
34,524
+10,344
+43% +$146K 0.07% 424
2024
Q3
$339K Buy
+24,180
New +$267K 0.04% 495
2024
Q1
Sell
-111,183
Closed -$759K 570
2023
Q4
$759K Hold
111,183
0.1% 326
2023
Q3
$556K Sell
111,183
-5,219
-4% -$36.1K 0.08% 373
2023
Q2
$1.06M Buy
116,402
+30,981
+36% +$289K 0.14% 245
2023
Q1
$807K Hold
85,421
0.15% 241
2022
Q4
$853K Buy
+85,421
New +$949K 0.16% 211

Other funds holding AXGN

Legato Capital Management's AXGN Position: Q2 2026 in Review

Legato Capital Management increased its Axogen (AXGN) stake by 22% in Q2 2026, buying an estimated $337K and bringing the position to 45,855 shares worth $2.12M. The position accounts for 0.18% of the portfolio, ranked #175.

Legato Capital Management first reported a position in AXGN in Q4 2022 and has held it in 11 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Legato Capital Management held 45,855 shares of Axogen worth $2.12M as of Q2 2026.
  • Legato Capital Management bought 8,350 Axogen shares in Q2 2026, an estimated $337K.
  • Axogen made up 0.18% of Legato Capital Management's portfolio in Q2 2026, its #175 holding.
  • Legato Capital Management first reported a position in Axogen in Q4 2022 and has held it in 11 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.